ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004

NIH Funding Opportunities Listed

March 13, 2009

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007